Grandview Asset Management LLC Atri Cure, Inc. Transaction History

Grandview Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 09, 2020	SELL	$24.49 - $43.84 $731,761 - $1.31 Million	-29,880 Closed	0 $0
Q4 2019 Jan 28, 2020	SELL	$24.06 - $32.51 $16,529 - $22,334	-687 Reduced 2.25%	29,880 $988,000
Q3 2019 Nov 07, 2019	SELL	$23.81 - $32.52 $55,477 - $75,771	-2,330 Reduced 7.08%	30,567 $736,000
Q2 2019 Jul 18, 2019	SELL	$26.85 - $30.74 $114,783 - $131,413	-4,275 Reduced 11.5%	32,897 $982,000
Q1 2019 May 07, 2019	SELL	$26.38 - $33.34 $10,552 - $13,336	-400 Reduced 1.06%	37,172 $996,000
Q4 2018 Feb 05, 2019	BUY	$26.66 - $34.85 $1 Million - $1.31 Million	37,572 New	37,572 $1.15 Million

204

48.3M

111K

23.8K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.65B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Grandview Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Grandview Asset Management LLC with notifications on news.